简介:Theeffectivenessofmechanicalventilation,bothinvasive(byendotrachealintubation)andnon-invasiive(bynegativepressureventilation)wasestablishedduringtheepidemicsofpolioinEuropeandNorthAmericainthelain1950sandearly1960s.Theindicationsforventilationhaveincreasedsincethattime,andinvasiveventilationserviceshavebecomeconcentratedinhighly-staffedcriticalcareunitsand.insomepartsofEurope,respiratorycareunits.
简介:可以预言未来的闪盘;夜猫子的好礼物;专为Wii设计的存储卡;太空水疗按摩浴缸;孩子们的圣诞礼物;游走天下;可以显示天气预报的咖啡机;iPod的好伙伴;慢炖;来自远方的问候;指引征途;把你的自行车放上墙。
简介:瞄准:评估影响多囊肝疾病的非侵略、侵略的治疗的结果的因素。方法:有到2006年6月的从1986年7月的完全的后续的病人的临床的文件的分析。结果:41个病人(男性,7;女性,34),11.9年变老的47.8+/-,和5.7+/-6.7年后续,被学习。硷性磷酸酯酶(AP)举起(15%病人)与侵略治疗的要求被联系(信息技术,P=0.005)。信息技术率是更高的在比非征兆的病人征兆(65.4%对14.3%,P=0.002),并且在拿神经质的代替治疗(HRT)的女人(P=0.001)。包囊复杂并发症(CC)是更经常的(22%)在征兆的病人组织(P=0.023)。有身体质量的病人索引(BMI)>(59%)25在它以后有一个趋势到复杂并发症(P=0.075)。腹的疼痛为信息技术(78%)是最普通的症状(56%)和指示。十九个病人(46%)要求了第一种信息技术:12开的开窗术(),4laparoscopic开窗术(LF)和有肝的切除术(FHR)的3开窗术。三要求了第二种信息技术,并且一个人要求了第三个过程。复杂并发症在32%由于第一种信息技术被发现(16.7%,LF25%,FHR66.7%),并且在在66.7%的第二种信息技术(100%)。后续死亡率是0。结论:症状,提高的AP,和CC的存在与信息技术要求被联系。HRT与症状和信息技术要求的存在被联系。有BMI>的病人25有一个趋势产生信息技术复杂并发症。复杂并发症的比例在FHR和秒信息技术组是更高的。RS是更经常的在以后。
简介:Non-invasiveventilation(NIV)istheprovisionofventilatorysupportwithoutinstrumentationoftheairway.Itcanbeachievedusinganegative-pressuremachine(e.g.‘ironlung')or,morecommonly,withpositivepressureadministeredthroughawell-fittingmask.Thiscontributionconsiderspositivepressureventilationonly;negativepressureisnowseldomused.
简介:MINICooper、MINI裙、MINIMP3播放器、MINI笔记本电脑……体积越小越能受到青睐,如果让你拥有一张MINI型的时尚银行卡是不是很酷?赶快行动吧,招商银行近期已经推出了一款VISAMINI信用卡,为什么说它MINI,原因是卡的面积比普通信用卡小43%,使用这样一张小巧玲珑的信用卡,顿时能让你的生活MINI起来!
简介:极速响应时间明基过去曾推出FP93V,外形与现时的FP93VW几乎完全一亲,两者的最大分别在于FP93VW配备了宽荧幕,反应时间亦由8毫秒加速至5毫秒,这两项改变有助于优化计算机的多媒体表现。
简介:AbstractBackground:Although existing mycological tests (bronchoalveolar lavage [BAL] galactomannan [GM], serum GM, serum (1,3)-β-D-glucan [BDG], and fungal culture) are widely used for diagnosing invasive pulmonary aspergillosis (IPA) in non-hematological patients with respiratory diseases, their clinical utility in this large population is actually unclear. We aimed to resolve this clinical uncertainty by evaluating the diagnostic accuracy and utility of existing tests and explore the efficacy of novel sputum-based Aspergillus assays.Methods:Existing tests were assessed in a prospective and consecutive cohort of patients with respiratory diseases in West China Hospital between 2016 and 2019 while novel sputum assays (especially sputum GM and Aspergillus-specific lateral-flow device [LFD]) in a case-controlled subcohort. IPA was defined according to the modified European Organization for Research and Treatment of Cancer/Mycoses Study Group criteria. Sensitivity and specificity were computed for each test and receiver operating characteristic (ROC) curve analysis was performed.Results:The entire cohort included 3530 admissions (proven/probable IPA = 66, no IPA = 3464) and the subcohort included 127 admissions (proven/probable IPA = 38, no IPA = 89). Sensitivity of BAL GM (≥1.0 optical density index [ODI]: 86% [24/28]) was substantially higher than that of serum GM (≥0.5 ODI: 38% [39/102]) (χ2 = 19.83, P < 0.001), serum BDG (≥70 pg/mL: 33% [31/95]) (χ2 = 24.65, P < 0.001), and fungal culture (33% [84/253]) (χ2 = 29.38, P < 0.001). Specificity varied between BAL GM (≥1.0 ODI: 94% [377/402]), serum GM (≥0.5 ODI: 95% [2130/2248]), BDG (89% [1878/2106]), and culture (98% [4936/5055]). Sputum GM (≥2.0 ODI) had similar sensitivity (84% [32/38]) (Fisher’s exact P = 1.000) to and slightly lower specificity (87% [77/89]) (χ2 = 5.52, P = 0.019) than BAL GM (≥1.0 ODI). Area under the ROC curve values were comparable between sputum GM (0.883 [0.812-0.953]) and BAL GM (0.901 [0.824-0.977]) (P = 0.734). Sputum LFD had similar specificity (91% [81/89]) (χ2 = 0.89, P = 0.345) to and lower sensitivity (63% [24/38]) (χ2 = 4.14, P = 0.042) than BAL GM (≥1.0 ODI), but significantly higher sensitivity than serum GM (≥0.5 ODI) (χ2 = 6.95, P = 0.008), BDG (χ2 = 10.43, P = 0.001), and fungal culture (χ2 = 12.70, P < 0.001).Conclusions:Serum GM, serum BDG, and fungal culture lack sufficient sensitivity for diagnosing IPA in respiratory patients. Sputum GM and LFD assays hold promise as rapid, sensitive, and non-invasive alternatives to the BAL GM test.
简介:BackgroundHybridcoronaryrevascularization(HCR)isanalternativecoronaryrevascularizationstrategythatcombinesaminimallyinvasive,survivaladvantageoftheleftinternalmammaryartery(LIMA)-leftanteriordescending(LAD)coronaryarterybypasswithless-invasivepercutaneouscoronaryintervention(PCI)tonon-LADcoronarylesionsbyusingdrug-elutingstents.Wereportourexperienceofhybridminimallyinvasiveapproachin15patients.MethodsFromDecember2012toOctober2013,15patientsunderwentrevascularizationoftheleftanteriordescendingarterythroughminimallyinvasivecoronaryarterybypassgrafting(MIDCAB).Allpatientsbyendoscopicassistbeatingheartcoronaryarterybypassgrafting.Sevenpatientswerescheduledforahybridprocedure.Percutaneouscoronaryinterventionofnon-LADwasperformed3to5dayspreoperatively.Demographicdata,perioperativeoutcome,andannualfollow-upwereobtainedfromallthepatients.ResultsIn-hospitalmortalitywas6.67%.Therateofconversiontofullmediansternotomywas13.3%.Ventilationtimewas6.9±5.1h.Bloodlossvolumewas241±67.8mL.ICUstaywas21.3±10.8h.Hospitalpostoperativestaylastedfor7.5±1.3days.PriortoPCIpatientsshowed100%patentLIMA(Tables3and4).Ameanfollow-upwas8.5months.Oneyeargraftpatencyratewas100%(8/8patientsfor254-slicetomography).Twopatientsrequiredreintervention.ConclusionsMinimallyinvasivehybridcoronaryrevascularizationisasafe,feasibleandefficaciousapproachwithgoodresultsandshouldbeperformedinselectedpatientsbysurgeonswithexperienceinminimallyinvasivebypasssurgerypluscollaborationwithcardiologists.elutingstents.
简介:Primaryandmetastaticlivertumorsareanincreasingglobalhealthproblem,withhepatocellularcarcinoma(HCC)nowbeingthethirdleadingcauseofcancer-relatedmortalityworldwide.SystemictreatmentoptionsforHCCremainlimited,withSorafenibastheonlyprospectivelyvalidatedagentshowntoincreaseoverallsurvival.Surgicalresectionand/ortransplantation,locallyablativetherapiesandregionalorlocoregionaltherapieshavefilledthegapinlivertumortreatments,providingimprovedsurvivaloutcomesforbothprimaryandmetastatictumors.Minimallyinvasivelocaltherapieshaveanincreasingroleinthetreatmentofbothprimaryandmetastaticlivertumors.Forpatientswithlowvolumedisease,thesetherapieshavenowbeenestablishedintoconsensuspracticeguidelines.Thisreviewhighlightstechnicalaspectsandoutcomesofcommonlyutilized,minimallyinvasivelocaltherapiesincludinglaparoscopicliverresection(LLR),radiofrequencyablation(RFA),microwaveablation(MWA),high-intensityfocusedultrasound(HIFU),irreversibleelectroporation(IRE),andstereotacticbodyradiationtherapy(SBRT).Inaddition,theroleofcombinationtreatmentstrategiesutilizingtheseminimallyinvasivetechniquesisreviewed.